HC Wainwright Reiterates “Buy” Rating for ArriVent BioPharma (NASDAQ:AVBP)

Published on 17 Nov 2024 on ETF DAILY NEWS

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report)‘s stock had its “buy” rating restated by research...

Read the rest of the article

Start tracking your investments with Statfolio

KBC Group NV lifted its position in shares of CAVA Group, Inc. (NYSE:CAVA – Free Report) by 40.8%...

ETF DAILY NEWS 21 Nov 2024

The brokerage presently has an “outperform” rating on the business services provider’s stock. Mac...

ETF DAILY NEWS 20 Nov 2024

Looking at individual holdings, Travelers Cos Inc/the (TRV) accounts for about 8.77% of total...

Zacks · via Yahoo Finance 19 Nov 2024

ArriVent BioPharma (NASDAQ:AVBP – Get Free Report)‘s stock had its “buy” rating restated by resea...

ETF DAILY NEWS 17 Nov 2024

Third Point, a hedge fund, filed its Form 13F on Thursday, revealing the fund's trades from the p...

Benzinga 15 Nov 2024

Key new holdings include: Brookfield Corp (NYSE:BN) with 4,725,000 shares, making up 3.38% of the...

GuruFocus.com · via Yahoo Finance 15 Nov 2024

AIG's SWOT analysis: insurance giant navigates market shifts, stock outlook

Investing.com 13 Nov 2024

The Credit One Bank Wander American Express Card is geared toward people who love to travel but m...

CNBC 11 Nov 2024

On Monday, Keefe, Bruyette & Woods updated their outlook on American International Group (NYSE:AI...

Investing.com 11 Nov 2024

Research analysts at StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Get...

ETF DAILY NEWS 10 Nov 2024